Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/22/2003CN1449766A Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449765A Puerarin soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449764A Roxithromycin slow-released pharmaceutics and preparation process thereof
10/22/2003CN1449763A Soy daidzin composition and preparation process and use thereof
10/22/2003CN1449758A Oral compound slow-released pharmaceutics containing theine and salmol active constituent and preparation process thereof
10/22/2003CN1449757A Domperidone oral disintegrating tablet and preparation process thereof
10/22/2003CN1449756A Difenidol Hydrochloride oral disintegrating tablet and preparation process thereof
10/22/2003CN1449755A Dextromethorphan hydrobromide drop pills and preparation process thereof
10/22/2003CN1449754A Edaravone medicine composition and preparation thereof
10/22/2003CN1449753A Chlorogenic acid and isochlorogenic acid composition and medical use thereof
10/22/2003CN1449750A Gabapentin slow -released composition
10/22/2003CN1449748A Dry powder microsphere inhalant for lung and preparation process thereof
10/22/2003CN1449747A Built natural vegetable gum and use in preparation of soft capsule
10/22/2003CN1449746A Soft capsule containing trace element
10/22/2003CN1449745A Coated solid hyponotic
10/22/2003CN1449744A Antifungal agent and preparation and use method
10/22/2003CN1449743A Medicinal aerosol and preparation process thereof
10/22/2003CN1449742A Insoluble medicine transdemal absorption preparation and process for preparing same
10/22/2003CN1449741A 栓塞材料 Embolic material
10/22/2003CN1449691A Anti-heatstroke effervescent beverage
10/22/2003CN1449689A Ginkgo health care food
10/22/2003CN1449681A Method for producing spices oil resin microcapsule
10/22/2003CN1125145C Stable aqueous dispersions and stable water-dispersible dry powders of xanthophylls and production and use of the same
10/22/2003CN1125049C New crystal modification N of torasemide
10/22/2003CN1124988C Activated medical water and its preparing process and usage
10/22/2003CN1124877C Solid and semi-solid hydrocarbon gels and use thereof
10/22/2003CN1124845C Proopofol microdroplet formulations
10/22/2003CN1124844C Stable freeze-dried pharmaceutical formulation
10/22/2003CN1124843C Stable glassy state powder formulations
10/22/2003CN1124842C Sustained release eyedrops
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635680 Controlled release pellet formulation
10/21/2003US6635678 Topical application of phenylephrine
10/21/2003US6635676 Non-toxic antimicrobial compositions and methods of use
10/21/2003US6635674 Oleic acid and/or oleyl alcohol; increasing skin absorption
10/21/2003US6635660 Methods of inhibiting sphincter incontinence
10/21/2003US6635654 Ophthalmic compositions containing loratadine
10/21/2003US6635628 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
10/21/2003US6635618 Glycopeptide phosphonate derivatives
10/21/2003US6635456 Generation of preferential phosphatides; obtain phosphatide, incubate with phosphatidyl glycerol, incubate phospholipase, recover phosphatide
10/21/2003US6635284 Delivery of multiple doses of medications
10/21/2003US6635283 Biocompatible particles having therapeutic, prophylactic or diagnostic agent, and of given mass mean diameter and aerodynamic diameter; at least 46% of the mass of particles are deposited after the first bifurcation of the lungs
10/21/2003US6635282 Gellan gum tablet film coating
10/21/2003US6635281 Comprising liquid active agent formulation absorbed in porous particles, particles being dispersed in a bioerodible carrier, dosage form being adapted to be retained within the stomach of subject for prolonged time
10/21/2003US6635280 Efficiency absorption in stomach; FDA Orange book listed patent for gabapentin
10/21/2003US6635279 Active ingredient-containing floating forms comprising polyvinyl acetate and polyvinylpyrrolidone, their use and production
10/21/2003US6635278 Nucleotide analog 9-(2-((bis((pivaloyloxy)methyl)phosphono)methoxy)ethyl) adenine and an alkaline excipient with or without L-carnitine-L- tartrate. The compositions are more stable
10/21/2003US6635277 Composition for pulsatile delivery of diltiazem and process of manufacture
10/21/2003US6635276 Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use
10/21/2003US6635275 Hydroxpropylated starch (HPS) or hydroxylethylated starch (HES) for the use in pharmaceutical, veterinary, food, cosmetic or wrapping or capsules, also including gum, cation and sequestering agent
10/21/2003US6635274 Solution-based transdermal drug delivery system
10/21/2003US6635273 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/21/2003US6635270 NMDA receptor agonist pharmaceutical compositions
10/21/2003US6635268 Sustained delivery of an active agent using an implantable system
10/21/2003US6635263 Sound skin condition can be maintained or created and/or deep relaxation can be appreciated, wherein a combination comprising a care cosmetic means and a comfort-stimulating means capable of acting on the mind
10/21/2003US6635262 Roll-on applicator comprising a hair composition
10/21/2003US6635253 Composition for enhancing immunological effects
10/21/2003US6635244 Adenovirus E1B-55K single amino acid mutants and methods of use
10/21/2003US6635243 Drug including genetically engineered alpha, beta or gamma interferon, biocompatible polymer selected from group consisting of polyvinylpyrrolidone and polyethylene oxide, and biocompatible antioxidant, and having specified viscosity
10/21/2003US6635237 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
10/21/2003US6635049 Drug bolus delivery system
10/21/2003US6635048 Implantable medical pump with multi-layer back-up memory
10/21/2003US6635045 Silver/silver chloride; reservoir comprising aqueous sodium chloride dispersed therein; corrosion resistance; transdermal
10/21/2003US6635014 Ambulatory medical apparatus and method having telemetry modifiable control software
10/21/2003US6634576 At least one composition of media bodies provides fragments of milling media bodies that are retained with the milled solid substrate particles in the form of a synergetic commixture produced in the milling process.
10/21/2003CA2293578C Selectively-activatible sheet material for dispensing and dispersing a substance onto a target surface
10/21/2003CA2291382C Direct action anti-mycotic
10/21/2003CA2225352C Vegetable derived petroleum jelly replacement
10/21/2003CA2169376C Procedure for encapsulating nsaids
10/21/2003CA2158166C Delayed release microtablet of .beta.-phenylpropiophenone derivatives
10/21/2003CA2141964C Pharmaceutical agents containing diphosphonic acids and salts thereof
10/21/2003CA2114239C Pharmaceutical composition containing carbachol and other cholinergic substances
10/21/2003CA2081344C Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
10/21/2003CA2037884C Stabilized gonadotropin containing preparations
10/16/2003WO2003085137A1 Antisense modulation of liver glycogen phosphorylase expression
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084768A1 Micro/nano-embossing process and useful applications thereof
10/16/2003WO2003084597A1 Device for intradermal medicament delivery
10/16/2003WO2003084595A1 Valved intradermal delivery device
10/16/2003WO2003084582A1 Embolization
10/16/2003WO2003084580A1 Hydrogel adhesives for use on hair or fiber-populated surfaces
10/16/2003WO2003084573A1 Polyfunctional biocompatible hydrogel and method for the production thereof
10/16/2003WO2003084564A1 Insulin administration apparatus
10/16/2003WO2003084563A1 Glp-1 agonist and cardiovascular complications
10/16/2003WO2003084553A1 Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis
10/16/2003WO2003084548A1 SOFT GELATINE CAPSULE CONTAINING A 17α ESTRADIOL AND ASCORBIC ACID
10/16/2003WO2003084539A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003WO2003084536A1 Oral administration of epothilones
10/16/2003WO2003084534A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
10/16/2003WO2003084520A2 Pharmaceutical preparation containing oxycodone and naloxone
10/16/2003WO2003084519A2 Aerosol formulation for inhalation comprising a tiotropium salt
10/16/2003WO2003084518A2 Oral suspension of active principle microcapsules
10/16/2003WO2003084517A2 Oral suspension of amoxicillin capsules
10/16/2003WO2003084516A1 Polysaccharide capsules and methods of preparation
10/16/2003WO2003084515A1 Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
10/16/2003WO2003084514A1 Controlled release pharmaceutical compositions of carbidopa and levodopa
10/16/2003WO2003084513A1 Controlled release solid dosage carbamazepine formulations
1 ... 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 ... 2991